Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) fell 0.4% on Monday . The company traded as low as $2.37 and last traded at $2.49. 4,479 shares traded hands during trading, a decline of 37% from the average session volume of 7,128 shares. The stock had previously closed at $2.50.
Nutriband Stock Performance
The stock has a 50 day moving average of $1.71 and a 200-day moving average of $1.84.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Read More
- Five stocks we like better than Nutriband
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- Best Stocks Under $10.00
- 3 High-Yield Banks for Investors to Buy on the Dip
- What is Put Option Volume?
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
